Aktiesnakken — December 2011
-
tillykke og glædelig jul
-
Det er da flot TORM har ubelejeliget sig med at lave finanskalender for hele 2012.
-
-
den var ond Kristensen!
-
-
BNP nedjusteres fra 2,0 til 1,8
-
jeps..
-
Så er vi oppe på 71 ofatumumab forsøg. 2nye idag! Har dog mistet overblikket over hvilke der er nye
-
To nye fase 2 forsøg med OFA+methylprednisolon og OFA+Lenalidomide i CLL
-
meget godt!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind